MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 39 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114,992 | +2682.3% | 9,326 | +2675.6% | 0.00% | – |
| Q2 2023 | $4,133 | -1.1% | 336 | -1.2% | 0.00% | – |
| Q1 2023 | $4,178 | – | 340 | +33900.0% | 0.00% | – |
| Q3 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 1 | -88.9% | 0.00% | – |
| Q1 2020 | $0 | – | 9 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 9 | -35.7% | 0.00% | – |
| Q3 2019 | $0 | – | 14 | -62.2% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 37 | -58.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 88 | -40.5% | 0.00% | – |
| Q4 2018 | $1,000 | -75.0% | 148 | -80.7% | 0.00% | – |
| Q3 2018 | $4,000 | -98.3% | 766 | -98.4% | 0.00% | – |
| Q2 2018 | $241,000 | -98.1% | 49,071 | -97.0% | 0.00% | -100.0% |
| Q1 2018 | $13,000,000 | -20.6% | 1,615,019 | +1.2% | 0.00% | 0.0% |
| Q4 2017 | $16,363,000 | -28.9% | 1,596,423 | +0.9% | 0.00% | -33.3% |
| Q3 2017 | $23,003,000 | – | 1,582,057 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Standard LLC | 869,354 | $2,895,000 | 3.47% |
| 22NW, LP | 1,241,896 | $4,136,000 | 2.24% |
| Newtyn Management, LLC | 1,199,606 | $3,995,000 | 1.46% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 186,198 | $620,000 | 0.35% |
| Yakira Capital Management, Inc. | 66,934 | $223,000 | 0.10% |
| Sepio Capital, LP | 210,534 | $701,000 | 0.08% |
| Nantahala Capital Management | 747,635 | $2,490,000 | 0.08% |
| Watson Rebecca | 3,068 | $10,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 61,700 | $205,000 | 0.00% |
| WEBSTER BANK, N. A. | 3,055 | $10,000 | 0.00% |